| Literature DB >> 28069573 |
Vanessa Bell1, Elizabeth L McCabe2, Martin G Larson2,3, Jian Rong3, Allison A Merz4, Ewa Osypiuk3, Birgitta T Lehman3, Plamen Stantchev3, Jayashri Aragam5, Emelia J Benjamin6,3,7, Naomi M Hamburg7,8, Ramachandran S Vasan6,3,7, Gary F Mitchell9, Susan Cheng10,4.
Abstract
BACKGROUND: Aortic stiffness impairs optimal ventricular-vascular coupling and left ventricular systolic function, particularly in the long axis. Left ventricular global longitudinal strain (GLS) has recently emerged as a sensitive measure of early cardiac dysfunction. In this study, we investigated the relation between aortic stiffness and GLS in a large community-based sample. METHODS ANDEntities:
Keywords: aortic stiffness; characteristic impedance; global longitudinal strain; left ventricle function; pulse wave velocity; ventricular/vascular coupling hemodynamics
Mesh:
Year: 2017 PMID: 28069573 PMCID: PMC5523643 DOI: 10.1161/JAHA.116.004903
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Sample Characteristics
| Variables | Men (N=1065) | Women (N=1430) |
|---|---|---|
| Age, y | 65±9 | 66±9 |
| Nonwhite race/ethnicity, N (%) | 90 (8) | 147 (10) |
| Height, cm | 175±7 | 161±6 |
| Weight, kg | 87±15 | 71±15 |
| Body mass index, kg/m2 | 28.5±4.5 | 27.4±5.6 |
| Seated blood pressure, mm Hg | ||
| Systolic | 129±16 | 127±18 |
| Diastolic | 76±10 | 73±10 |
| Glucose, mg/dL | 109±24 | 102±20 |
| Total/HDL cholesterol ratio | 3.7±1.1 | 3.3±1.0 |
| Triglycerides, mg/dL | 101 (73, 144) | 99 (73, 135) |
| Diabetes mellitus, N (%) | 171 (16) | 130 (9) |
| Current smoker, N (%) | 82 (8) | 129 (9) |
| Hypertension treatment, N (%) | 543 (51) | 646 (45) |
| Lipid treatment, N (%) | 517 (49) | 578 (40) |
Values are shown as means±SD or number (percent frequency) unless otherwise indicated. HDL indicates high‐density lipoprotein.
Median (25th, 75th percentile).
Included Versus Excluded Sample Characteristics
| Variables | Included (N=2495) | Excluded (N=824) |
|---|---|---|
| Age, y | 65±9 | 71±10 |
| Women, N (%) | 1430 (57) | 419 (51) |
| Nonwhite race/ethnicity, N (%) | 237 (10) | 61 (7) |
| Height, cm | 167±10 | 167±10 |
| Weight, kg | 78±17 | 82±20 |
| Body mass index, kg/m2 | 27.9±5.2 | 30.0±6.2 |
| Seated blood pressure, mm Hg | ||
| Systolic | 128±17 | 130±18 |
| Diastolic | 74±10 | 71±11 |
| Glucose, mg/dL | 105±22 | 112±30 |
| Total/HDL cholesterol ratio | 3.5±1.0 | 3.5±1.1 |
| Triglycerides, mg/dL | 100 (73, 138) | 107 (75, 153) |
| Diabetes mellitus, N (%) | 301 (12) | 179 (25) |
| Current smoker, N (%) | 211 (8) | 73 (9) |
| Hypertension treatment, N (%) | 1189 (48) | 619 (75) |
| Lipid treatment, N (%) | 1095 (44) | 490 (60) |
Values are shown as means±SD or number (percent frequency) unless otherwise indicated. HDL indicates high‐density lipoprotein.
Median (25th, 75th percentile).
Vascular and Cardiac Measures
| Variables | Men (N=1065) | Women (N=1430) |
|---|---|---|
| Tonometric measures | ||
| Heart rate, min−1 | 59±10 | 61±10 |
| Supine blood pressure, mm Hg | ||
| Systolic | 140±19 | 140±20 |
| Diastolic | 70±9 | 69±9 |
| Mean | 98±11 | 98±12 |
| Pulse pressure | 70±17 | 71±19 |
| Carotid–femoral pulse wave velocity, m/s | 10.6±3.7 | 9.9±3.4 |
| Negative inverse CFPWV, ms/m | −103±28 | −110±29 |
| Characteristic impedance (Zc), dyne·s/cm5 | 218±74 | 262±104 |
| Log‐characteristic impedance, dyne·s/cm5 | 5.3±0.3 | 5.5±0.4 |
| Augmentation index | 10.5±10.5 | 16.9±12.5 |
| Echocardiographic measures | ||
| LV wall thickness, cm | 2.1±0.2 | 1.8±0.2 |
| LV end‐diastolic dimension, cm | 5.1±0.4 | 4.6±0.4 |
| LV mass, g | 195.2±41.6 | 139.8±30.8 |
| LV ejection fraction, % | 65.7±6.8 | 69.1±6.3 |
| Global longitudinal strain (GLS), % | −19.7±2.9 | −21.5±3.2 |
| Global circumferential strain (GCS), % | −31.0±5.5 | −33.1±5.7 |
Values are shown as means±SD or number (percent frequency) unless otherwise indicated. CFPWV indicates carotid–femoral pulse wave velocity; LV, left ventricular.
Multivariable‐Adjusted Associations of Hemodynamic Measures With Indices of LV Strain
| Vascular Measures | Global Longitudinal Strain (GLS) | Global Circumferential Strain (GCS) | ||
|---|---|---|---|---|
| Coefficient (SE) |
| Coefficient (SE) |
| |
| Negative inverse CFPWV | ||||
| Model 1 | 0.211 (0.024) | <0.0001 | 0.077 (0.026) | 0.003 |
| Model 2 | 0.099 (0.029) | 0.0005 | 0.038 (0.031) | 0.22 |
| Model 3 | 0.122 (0.030) | <0.0001 | 0.063 (0.032) | 0.05 |
| Log‐Zc | ||||
| Model 1 | 0.095 (0.023) | <0.0001 | 0.051 (0.024) | 0.04 |
| Model 2 | 0.082 (0.028) | 0.003 | 0.080 (0.030) | 0.008 |
| Model 3 | 0.090 (0.029) | 0.002 | 0.109 (0.031) | 0.0005 |
Model 1 is adjusted for cohort, age, sex, and height. Model 2 is adjusted for the covariates in Model 1 plus weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, and augmentation index. Model 3 is adjusted for the covariates in Model 2 plus LV mass, LV wall thickness, and LV end‐diastolic dimension. CFPWV indicates carotid–femoral pulse wave velocity; HDL, high‐density lipoprotein; Zc, characteristic impedance; LV, left ventricular.
Coefficients denote estimated variation in the cardiac strain measure (dependent variable in units of SD) per 1 SD of the hemodynamic measure (independent variable). The sex‐pooled mean±SD of negative inverse CFPWV was −107±29 ms/m; thus, 1 SD higher negative inverse CFPWV corresponds to a reverse‐transformed difference of 3.5 m/s (the difference between −107 and −107+29 transformed back to native units). The sex‐pooled mean±SD for Log‐Zc was 5.4±0.4; thus, 1 SD higher Log‐Zc corresponds to an inverse transformed 1 SD difference of 95 dyne·s/cm5. Thus, Model 3 results indicate that a CFPWV that was 3.5 m/s higher than the mean would be associated with a 0.12 SD higher (worse) GLS.
Relations between Log‐Zc and GLS exhibited a sex‐interaction (Table 5). Analyses were therefore repeated for men and women separately (Model 2: Men −0.012 [0.041] P=0.77, Women 0.146 [0.037] P<0.0001; Model 3: Men 0.015 [0.043] P=0.73, Women: 0.145 [0.039] P=0.0003).
Figure 1Multivariable adjusted associations between carotid–femoral pulse wave velocity (CFPWV) and (A) global longitudinal strain (GLS) and (B) global circumferential strain (GCS). GLS was significantly worse (less negative) with greater CFPWV, and GCS was significantly worse (less negative) with greater CFPWV. Analyses were adjusted for key covariates: cohort, age, sex, height, weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, augmentation index, left ventricular mass, left ventricular wall thickness, and left ventricular diastolic dimension. The symbol Δ refers to difference in GLS or GCS compared to the median per CFPWV value. CL indicates confidence limit; HDL, high‐density lipoprotein.
Figure 2Multivariable adjusted associations between characteristic impedance (Zc) and global longitudinal strain (GLS) in (A) men and (B) women and between Zc and global circumferential strain (GCS) in (C) men and (D) women. Greater Zc was not significantly associated with either GLS or GCS in men; by contrast, Zc was associated with significantly worse (less negative) GLS and GCS. Analyses were adjusted for key covariates: cohort, age, sex, height, weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, augmentation index, left ventricular mass, left ventricular wall thickness, and left ventricular diastolic dimension. The symbol Δ refers to difference in GLS or GCS compared to the median per Zc value. CL indicates confidence limit; HDL, high‐density lipoprotein.
Age and Sex Interactions in Multivariable‐Adjusted Associations
| Vascular Measures | Longitudinal Strain (GLS) | Circumferential Strain (GCS) | ||
|---|---|---|---|---|
| Coefficient (SE) |
| Coefficient (SE) |
| |
| Age interaction terms | ||||
| Age×(negative inverse CFPWV) | ||||
| Model 2 | 0.024 (0.044) | 0.58 | 0.026 (0.047) | 0.58 |
| Model 3 | 0.065 (0.046) | 0.16 | 0.056 (0.049) | 0.25 |
| Age×Log‐Zc | ||||
| Model 2 | −0.0004 (0.041) | 0.99 | 0.022 (0.044) | 0.62 |
| Model 3 | 0.009 (0.043) | 0.83 | 0.034 (0.045) | 0.45 |
| Sex interaction terms | ||||
| Sex×(negative inverse CFPWV) | ||||
| Model 2 | 0.044 (0.039) | 0.27 | −0.065 (0.042) | 0.12 |
| Model 3 | 0.049 (0.042) | 0.24 | −0.082 (0.044) | 0.06 |
| Sex×Log‐Zc | ||||
| Model 2 | 0.118 (0.040) | 0.004 | 0.016 (0.044) | 0.72 |
| Model 3 | 0.107 (0.042) | 0.01 | 0.021 (0.045) | 0.65 |
Model 2 is adjusted for cohort, age, sex, height, weight, glucose, total/HDL cholesterol ratio, natural log‐triglycerides, diabetes mellitus, current smoker, antihypertensive medication use, lipid‐lowering medication use, heart rate, systolic blood pressure, and augmentation index. Model 3 is adjusted for the covariates in Model 2 plus LV mass, LV wall thickness, and LV end‐diastolic dimension. CFPWV indicates carotid–femoral pulse wave velocity; GCS, global circumferential strain; GLS, global longitudinal strain; HDL, high‐density lipoprotein; LV, left ventricular; Zc, characteristic impedance.
Coefficients are for the age interaction term (older vs younger age was defined by the median age [65 years]) or the sex interaction term (testing for difference in slopes between women vs men) as independent measures in the multivariable models.